By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Max Delbruck Center 

Robert-Rössle-Str. 10
Berlin    13092  Germany
Phone: 49-30-9406-0 Fax: 49-30-949-4161



Company News
MediGene AG (MDGEF.PK) Joins Max Delbruck Center And Charité For First Clinical TCR Study In Germany 6/29/2016 11:45:31 AM
Formula Pharmaceuticals, Inc. And The Max Delbruck Center For Molecular Medicine Enter Into An Exclusive Licensing Agreement And Strategic Collaboration To Develop C.I.K. CAR Immunotherapies 8/3/2015 10:18:34 AM
Alzheimer's Disease Protein Controls Movement In Mice, Max Delbruck Center Study 6/24/2013 7:24:17 AM
14 New Biomarkers Identified for Type 2 Diabetes, German Institute of Human Nutrition (DIfE) and Max Delbruck Center Study 10/5/2012 7:39:44 AM
Dementia: Autoantibodies Damage Blood Vessels in the Brain, Max Delbruck Center Study 8/1/2012 7:30:29 AM
Touch Sensitivity is Genetically Linked to Hearing, Max Delbruck Center Study 5/15/2012 7:00:52 AM
People With DFNA2 Hearing Loss Show Increased Touch Sensitivity, Max Delbruck Center Study 12/13/2011 7:19:32 AM
A Natural Dye Obtained from Lichens May Combat Alzheimer’s Disease, Max Delbruck Center Study 12/5/2011 7:27:14 AM
German Chancellor Angela Merkel Starts the New Pacific Biosciences RS at the Max Delbruck Center 9/13/2011 10:51:14 AM
New Blood Tests From OncoMethylome Sciences S.A. And the ECRC Charite University of Medicine and the Max Delbruck Center Promise Simple Cancer Detection 9/21/2009 7:03:30 AM